Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains
Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use
Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read
Key Points: In today’s Recommendation for Industry, we discuss how cases seem to be improving and moving across the country, as shown through the CDC
Key Points: In today’s Recommendations for Industry, we discuss COVID-19 trends stabilizing and declining. Read more below. The CDC released research done on post-COVID conditions
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
